Primary extranodal head and neck classical Hodgkin lymphoma: A rare clinical case report

Men,Yongzhi; Sun,Xuemei; Wei,Daolin; Yu,Ziwei

doi:10.3892/etm.2016.3374

Primary extranodal head and neck classical Hodgkin lymphoma: A rare clinical case report

Authors:
- Yongzhi Men
- Xuemei Sun
- Daolin Wei
- Ziwei Yu
View Affiliations

Affiliations: Department of Otorhinolaryngology-Head and Neck Surgery, Shanghai General Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200080, P.R. China, Department of Pathology, Shanghai General Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200080, P.R. China, Department of Hematology, Shanghai General Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200080, P.R. China
Published online on: May 20, 2016 https://doi.org/10.3892/etm.2016.3374
Pages: 1007-1011
Copyright: © Men et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The subcutaneous soft tissue of the forehead is a rare anatomic site for Hodgkin lymphoma (HL), and no such case has previously been reported in the literature, to the best of our knowledge. HLs commonly present in the nodal regions in the majority of patients, rarely occurring in extranodal sites, whereas primary extranodal lymphoma is less common and is more typical in cases of non‑HL. The present study reports a novel case of extranodal head and neck classical HL (cHL), initially diagnosed as frontal fibroma. The present study describes an unusual case of subcutaneous soft tissue involvement of HL, aiming to enhance current levels of awareness for patients with extranodal symptoms. A 25-year-old male, who inadvertently detected a hard painless mass above the right superciliary arch 2 months prior to admission in April 2013 was eventually diagnosed with mixed cellularity cHL. Subsequent to six cycles of doxorubicin (Adriamycin), bleomycin, vindesine and dacarbazine chemotherapy, followed by four cycles of ifosfamide, gemcitabine, vinorelbine and prednisone chemotherapy, a satisfactory curative effect was obtained. In conclusion, it is proposed that lymphoma should be considered in the differential diagnosis of a mass involving the subcutaneous soft tissue.

View Figures

View References

1	Gobbi PG, Ferreri AJ, Ponzoni M and Levis A: Hodgkin lymphoma. Crit Rev Oncol Hematol. 85:216–237. 2013. View Article : Google Scholar : PubMed/NCBI
2	Cartwright R, Brincker H, Carli PM, Clayden D, Coebergh JW, Jack A, McNally R, Morgan G, de Sanjose S, Tumino R and Vornanen M: The rise in incidence of lymphomas in Europe 1985–1992. Eur J Cancer. 35:627–633. 1999. View Article : Google Scholar : PubMed/NCBI
3	Weber AL, Rahemtullah A and Ferry JA: Hodgkin and non-Hodgkin lymphoma of the head and neck: Clinical, pathologic and imaging evaluation. Neuroimaging Clin N Am. 13:371–392. 2003. View Article : Google Scholar : PubMed/NCBI
4	Dirim B, Karakas L, Oyar O, Bener S, Sener M, Yagtu M, Erdogan N, Uluc E and Altay C: An unusual Hodgkin's lymphoma case presenting with upper extremity multiple masses. Clin Imaging. 36:873–876. 2012. View Article : Google Scholar : PubMed/NCBI
5	Travis WD, Banks PM and Reiman HM: Primary extranodal soft tissue lymphoma of the extremities. Am J Surg Pathol. 11:359–366. 1987. View Article : Google Scholar : PubMed/NCBI
6	Neskoromna-Jędrzejczak A, Tyndorf M, Arkuszewski P and Kobos J: Head and neck lymphomas-diagnostic difficulties. Pol Przegl Chir. 84:113–118. 2012.PubMed/NCBI
7	Kashyap R, Rai Mittal B, Manohar K, Balasubramanian Harisankar CN, Bhattacharya A, Singh B, Malhotra P and Varma S: Extranodal manifestations of lymphoma on [¹⁸F]FDG-PET/CT: A pictorial essay. Cancer Imaging. 11:166–174. 2011. View Article : Google Scholar : PubMed/NCBI
8	Diehl V, Sextro M, Franklin J, Hansmann ML, Harris N, Jaffe E, Poppema S, Harris M, Franssila K, van Krieken J, et al: Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: Report from the European Task Force on Lymphoma project on lymphocyte-predominant Hodgkin's disease. J Clin Oncol. 17:776–783. 1999.PubMed/NCBI
9	Guermazi A, Brice P, de Kerviler EE, Fermé C, Hennequin C, Meignin V and Frija J: Extranodal Hodgkin disease: Spectrum of disease. Radiographics. 21:161–179. 2001. View Article : Google Scholar : PubMed/NCBI
10	Ilica AT, Kocacelebi K, Savas R and Ayan A: Imaging of extranodal lymphoma with PET/CT. Clin Nucl Med. 36:e127–e138. 2011. View Article : Google Scholar : PubMed/NCBI
11	Andjelic B, Antic D, Jakovic L, Todorovic M, Bogdanovic A, Djurasinovic V, Bila J and Mihaljevic B: A single institution experience on 314 newly diagnosed advanced Hodgkin lymphoma patients: The role of ABVD in daily practice. Eur J Haematol. 93:392–399. 2014. View Article : Google Scholar : PubMed/NCBI
12	Suárez AL, Pulitzer M, Horwitz S, Moskowitz A, Querfeld C and Myskowski PL: Primary cutaneous B-cell lymphomas: Part I. Clinical features, diagnosis and classification. J Am Acad Dermatol. 69(329): e1–e13; quiz 341–342. 2013.
13	White RM and Patterson JW: Cutaneous involvement in Hodgkin's disease. Cancer. 55:1136–1145. 1985. View Article : Google Scholar : PubMed/NCBI
14	Tamaru J: Pathological diagnosis of Hodgkin lymphoma. Nihon Rinsho. 72:450–455. 2014.(In Japanese). PubMed/NCBI
15	Loo EY, Medeiros LJ, Aladily TN, Hoehn D, Kanagal-Shamanna R, Young KH, Lin P, Bueso-Ramos CE, Manning JT Jr, Patel K, et al: Classical Hodgkin lymphoma arising in the setting of iatrogenic immunodeficiency: A clinicopathologic study of 10 cases. Am J Surg Pathol. 37:1290–1297. 2013. View Article : Google Scholar : PubMed/NCBI
16	Seymour JF: X. Extra-nodal lymphoma in rare localisations: Bone, breast and testes. Hematol Oncol. 31(Suppl 1): S60–S63. 2013. View Article : Google Scholar
17	Panico L, Tenneriello V, Ronconi F, Lepore M, Cantore N, Dell'Angelo AC, Ferbo L and Ferrara F: High CD20⁺ background cells predict a favorable outcome in classical Hodgkin lymphoma and antagonize CD68⁺ macrophages. Leuk Lymphoma. 56:1636–1642. 2015. View Article : Google Scholar : PubMed/NCBI
18	Kamper P, Bendix K, Hamilton-Dutoit S, Honoré B, Nyengaard JR and d'Amore F: Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma. Haematologica. 96:269–276. 2011. View Article : Google Scholar : PubMed/NCBI
19	Lister TA, Crowther D, Sutcliffe SB, Glatstein E, Canellos GP, Young RC, Rosenberg SA, Coltman CA and Tubiana M: Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol. 7:1630–1636. 1989.PubMed/NCBI
20	Yung L and Linch D: Hodgkin's lymphoma. Lancet. 361:943–951. 2003. View Article : Google Scholar : PubMed/NCBI
21	Talpur R1, Venkatarajan S and Duvic M: Mechlorethamine gel for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma. Expert Rev Clin Pharmacol. 7:591–597. 2014. View Article : Google Scholar : PubMed/NCBI
22	Möbs M, Cerroni L, Flaig MJ, Lenze D, Hummel M and Assaf C: Molecular diagnostics in cutaneous lymphomas. J Dtsch Dermatol Ges. 4:25–35. 2013. View Article : Google Scholar
23	Jerusalem G, Beguin Y, Fassotte MF, Najjar F, Paulus P, Rigo P and Fillet G: Whole-body positron emission tomography using ¹⁸F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease. Haematologica. 86:266–273. 2001.PubMed/NCBI
24	Jhanwar YS and Straus DJ: The role of PET in lymphoma. J Nucl Med. 47:1326–1334. 2006.PubMed/NCBI
25	Connors JM, Klimo P, Adams G, Burns BF, Cooper I, Meyer RM, O'Reilly SE, Pater J, Quirt I, Sadura A, et al: Treatment of advanced Hodgkin's disease with chemotherapy-comparison of MOPP/ABV hybrid regimen with alternating courses of MOPP and ABVD: A report from the National Cancer Institute of Canada clinical trials group. J Clin Oncol. 15:1638–1645. 1997.PubMed/NCBI
26	Canellos GP, Anderson JR, Propert KJ, Nissen N, Cooper MR, Henderson ES, Green MR, Gottlieb A and Peterson BA: Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med. 327:1478–1484. 1992. View Article : Google Scholar : PubMed/NCBI